drug · protein
patient view →lonapegsomatropin LA
Phase 3updated 2mo agoby Ascendis Pharma AS🔗 ChEMBL
Phase 3community read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with an approval for pituitary dwarfism and growth delay and 3 investigational indications.
targets
Growth hormone receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that